For laboratories and companies looking to accelerate protein research and development, BioLinker offers innovative solutions and services. The biotechnology and synthetic biology startup, which develops research kits and tools based on cell-free protein synthesis technology, has now raised $1.6M in new capital.
Founded by scientists for scientists, BioLinker aims to make protein development faster, more predictable, and more accessible for academic and industrial applications. Its cell-free protein synthesis technology enables shorter development cycles, helping clients achieve greater practicality, quality, and reliability in their work. The company positions itself as a proactive scientific partner, providing expertise and personalized guidance.


















